What is CG Oncology's change in AP?

CG Oncology (CGON) reported change in AP of $2.52M in Q1 2026.

How has CG Oncology's change in AP changed year-over-year?

CG Oncology's change in AP increased by 1078.5% year-over-year, from $214K to $2.52M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

CG Oncology CGON Change in AP

Change in AP at other companies

PfizerPFE

-$117.25M+54.2%

Johnson & JohnsonJNJ

-$3.92B-84.4%

Gilead SciencesGILD

-$67M+36.2%

ImmunityBio, Inc.IBRX

$3.9M-39.4%

Cogent Biosciences, Inc.COGT

$4.24M+98.0%

Tango TherapeuticsTNGX

$1.79M+9.5%

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's change in AP?: CG Oncology (CGON) reported change in AP of $2.52M in Q1 2026.
How has CG Oncology's change in AP changed year-over-year?: CG Oncology's change in AP increased by 1078.5% year-over-year, from $214K to $2.52M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.